Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Therapeutic Solutions International Inc TSOI

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene... see more

Recent & Breaking News (OTCPK:TSOI)

Therapeutic Solutions International Announces Appointment of Dr. Thomas E. Ichim to its Subsidiary Emvolio, Inc.

Marketwired May 1, 2017

Therapeutic Solutions International's Subsidiary OmniBiome, Inc. Announces First Oral Microbiome Therapy for Periodontal Disease

Marketwired April 24, 2017

Therapeutic Solutions International's Subsidiary, Emvolio, Inc., Files Investigational New Drug Application for StemVacs Cancer Immunotherapy

Marketwired April 12, 2017

Therapeutic Solutions International Announces Filing of new Immunotherapy Patent and Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.

Marketwired April 10, 2017

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

Marketwired February 6, 2017

Therapeutic Solutions International's Subsidiary MolecuVax, Inc. Announces Licensing of "Universal Cancer Vaccine" With Demonstrated Efficacy in Breast Cancer

Marketwired May 9, 2016

Therapeutic Solutions International Files Patent Covering ProJuvenol(C) and Its Active Ingredient Pterostilbene

Marketwired April 28, 2016

Therapeutic Solutions International's Subsidiary MolecuVax, Inc. to Initiate Cancer Immunotherapy Clinical Trial Aimed at Eradicating Cancer Stem Cells Using MVAX-001

Marketwired April 11, 2016

Therapeutic Solutions International Announces the Appointment of Dr. Hong Ma as Chief Scientific Officer

Marketwired March 16, 2016

Therapeutic Solutions International Announces the Licensing of Exosome Technology to MolecuVax, Inc.

Marketwired February 8, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre

Marketwired January 25, 2016

Therapeutic Solutions International Announces the Appointment of BioPharmaceutical Pioneer Thomas E. Ichim, Ph.D to Board of Directors

Marketwired January 22, 2016

Therapeutic Solutions International Announces the Appointment of Dr. Barry Glassman to the TSI Scientific Advisory Board

Marketwired January 5, 2016

Therapeutic Solutions International Announces the Licensing of Probiotic Technology to OmniBiome, Inc.

Marketwired December 8, 2015

Therapeutic Solutions International Files Patent on Anticancer Nanotechnology Based Immunotherapy

Marketwired November 23, 2015

Therapeutic Solutions International Announces the Licensing of Patents to OmniBiome and the Appointment of Iryna Dzieciuch, M.S. as Chief Executive Officer of OmniBiome

Marketwired November 18, 2015

Therapeutic Solutions International Announces the Appointment of Michael G. Agadjanyan, Ph.D. to Company Scientific Advisory Board

Marketwired October 19, 2015

Therapeutic Solutions International Announces the Appointment of Harry M. Lander, Ph.D. to the TSI Scientific Advisory Board

Marketwired October 12, 2015

Therapeutic Solutions International, Inc. Announces the Appointment of Santosh Kesari, M.D., Ph.D. to Company Scientific Advisory Board

Marketwired October 6, 2015

Therapeutic Solutions International Files Patent on Immune Therapy Medical Device to Prevent Preterm Labor

Marketwired September 29, 2015